Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 9;5(28):17743-17752.
doi: 10.1021/acsomega.0c02365. eCollection 2020 Jul 21.

Synthesis, Biochemical Characterization, and Theoretical Studies of Novel β-Keto-enol Pyridine and Furan Derivatives as Potent Antifungal Agents

Affiliations

Synthesis, Biochemical Characterization, and Theoretical Studies of Novel β-Keto-enol Pyridine and Furan Derivatives as Potent Antifungal Agents

Said Tighadouini et al. ACS Omega. .

Abstract

In the present study, we report the design and synthesis of new derivatives of the β-keto-enol grafted on pyridine and furan moieties (L 1 -L 11 ). Structures of compounds were fully confirmed by Fourier transform infrared spectroscopy (FT-IR), 1H NMR, 13C NMR, electrospray ionization/liquid chromatography-mass spectrometry (ESI/LC-MS), and elemental analysis. The compounds were screened for antifungal and antibacterial activities (Escherichia coli, Bacillus subtilis, and Micrococcus luteus). In vitro evaluation showed significant fungicidal activity for L 1 , L 4 , and L 5 against fungal strains (Fusarium oxysporum f.sp albedinis) compared to the reference standard. Especially, the exceptional activity has been demonstrated for L 1 with IC50 = 12.83 μg/mL. This compound and the reference benomyl molecule also showed a correlation between experimental antifungal activity and theoretical predictions by Petra/Osiris/Molinspiration (POM) calculations and molecular coupling against the Fgb1 protein. The highest inhibition of bacterial growth for L 1 is due to its strongest binding to the target protein. This report may stimulate the further synthesis of examples of this substance class for the development of new drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Molecular structures of some drugs containing keto-enol functionality.
Scheme 1
Scheme 1. Synthetic Route for the Compounds L1L11
Figure 2
Figure 2
R substituent for L1, L4, and L5.
Figure 3
Figure 3
Antibacterial and antifungal pharmacophore sites for L1.
Figure 4
Figure 4
Binding conformations predicted from the ADVina runs for benomyl (a), L1 (b), and L4 (c) bound to β-tubulin of F. oxysporum. The protein (Fgb1) binding site is shown by the molecular surface and colored according to the protein atomic composition. All protein residues are drawn as ball-and-stick models. Hydrogen bonds are visualized as dashed lines. The ligand molecules are depicted in sticks, and hydrogen atoms were removed to enhance clarity.

Similar articles

Cited by

References

    1. Fisher M. C.; Henk D. A.; Briggs C. J.; Brownstein J. S.; Madoff L. C.; McCraw S. L.; Gurr S. L. Emerging fungal threats to animal, plant and ecosystem health. Nature 2012, 484, 186–194. 10.1038/nature10947. - DOI - PMC - PubMed
    1. Nicola A. M.; Albuquerque P.; Paes H. C.; Fernandes L.; Costa F. F.; Kioshima E. S.; Abadio A. K. R.; Bocca A. L.; Felipe M. S. Antifungal drugs: new insights in research & development. Pharmacol. Ther. 2019, 195, 21–38. 10.1016/j.pharmthera.2018.10.008. - DOI - PubMed
    1. Brown G. D.; Denning D. W.; Gow N. A.; Levitz S. M.; Netea M. G.; White T. C. Hidden killers: human fungal infections. Sci. Transl. Med. 2012, 4, 165rv1310.1126/scitranslmed.3004404. - DOI - PubMed
    1. Xie G. H.; Fang X. M.; Fang Q.; Wu X. M.; Jin Y. H.; Wang J. L.; Guo Q. L.; Gu M. N.; Xu Q. P.; Wang D. X.; Yao S. L.; Yuan S. Y.; Du Z. H.; Sun Y. B.; Wang H. H.; Wu S. J.; Cheng B. L. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit. Care 2008, 12, R5.10.1186/cc6766. - DOI - PMC - PubMed
    1. Ramana K. V.; Kandi S.; Bharatkumar V.; Sharada C. V.; Rao R.; Mani R.; Rao S. D. Invasive fungal infections: a comprehensive review. Am. J. Infect. Dis. Microbiol. 2013, 1, 64–69. 10.12691/ajidm-1-4-2. - DOI